Holen Sie sich die Stockscreener-App
2.23
1.36%
0.03
Handel nachbörslich:
2.24
0.01
+0.45%
Schlusskurs vom Vortag:
$2.20
Offen:
$2.23
24-Stunden-Volumen:
7.98M
Relative Volume:
1.22
Marktkapitalisierung:
$1.43B
Einnahmen:
$2.45B
Nettoeinkommen (Verlust:
$-137.40M
KGV:
-10.82
EPS:
-0.2061
Netto-Cashflow:
$333.90M
1W Leistung:
-13.90%
1M Leistung:
-1.76%
6M Leistung:
-35.36%
1J Leistung:
-50.00%
1-Tages-Spanne:
$2.21
$2.365
1-Wochen-Bereich:
$2.09
$2.60
52-Wochen-Spanne:
$1.66
$4.77
Clarivate Plc Stock (CLVT) Company Profile
Firmenname
Clarivate Plc
Sektor
Telefon
(207) 433-4000
Adresse
4TH FLOOR, ST. PAUL'S GATE, ST. HELIER
Compare CLVT vs IBM, ACN, INFY, FISV, FIS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLVT
Clarivate Plc
|
2.23 | 1.43B | 2.45B | -137.40M | 333.90M | -0.2061 |
IBM
International Business Machines Corp
|
287.56 | 270.27B | 68.91B | 10.73B | 12.26B | 11.31 |
ACN
Accenture Plc
|
135.23 | 82.75B | 72.11B | 7.80B | 12.50B | 12.21 |
INFY
Infosys Ltd Adr
|
10.94 | 44.30B | 20.21B | 3.33B | 3.87B | 0.8084 |
FISV
Fiserv Inc
|
50.45 | 26.90B | 21.09B | 3.22B | 4.17B | 5.8948 |
FIS
Fidelity National Information Services Inc
|
41.98 | 21.70B | 11.44B | 2.68B | 1.93B | 5.1706 |
Clarivate Plc Stock (CLVT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-08 | Herabstufung | Goldman | Buy → Neutral |
| 2025-12-17 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-09-03 | Eingeleitet | Wolfe Research | Peer Perform |
| 2025-07-18 | Herabstufung | Jefferies | Buy → Hold |
| 2024-11-06 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-12-15 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2023-10-16 | Hochstufung | Jefferies | Hold → Buy |
| 2023-09-08 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2023-08-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-08-07 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-08-04 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-06-13 | Eingeleitet | Oppenheimer | Outperform |
| 2023-03-15 | Fortgesetzt | BofA Securities | Neutral |
| 2023-02-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-13 | Eingeleitet | Wells Fargo | Overweight |
| 2022-02-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-02-03 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-12-21 | Fortgesetzt | Citigroup | Buy |
| 2021-12-13 | Fortgesetzt | Goldman | Buy |
| 2021-08-16 | Eingeleitet | BofA Securities | Buy |
| 2021-08-04 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2021-03-31 | Eingeleitet | Jefferies | Buy |
| 2021-03-11 | Fortgesetzt | Citigroup | Buy |
| 2021-03-08 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
Alle ansehen
Clarivate Plc Aktie (CLVT) Neueste Nachrichten
Clarivate (CLVT) to Sell Life Sciences & Healthcare Business to Altaris For $600 Million - Yahoo Finance
Clarivate to sell life sciences unit to Altaris for $600M, refocus core business - MSN
Clarivate jumps 16% on $600M sale of life sciences segment - MSN
Clarivate to Report Second Quarter 2026 Results on July 29, 2026 - Finviz
Clarivate Shareholder Notice - TMX Newsfile
Clarivate Update - TMX Newsfile
Enterprise value to revenue forward of Clarivate PLC – MUN:16A - TradingView
Exploring the impact of G20 R&D investment - Clarivate
Improving research funding outcomes with AI‑native research intelligence - Clarivate
Clarivate PLC Actuals & Estimates (TRADEGATE:16A) - TradingView
Latham Advises on Financing for Altaris’ Acquisition of Clarivate’s Life Sciences & Healthcare Business - Latham & Watkins LLP
Clarivate (CLVT) Sells Life Sciences Division for $600 Million - GuruFocus
Clarivate (CLVT) Affirms FY26 Financial Projections Amid Segment Changes - GuruFocus
Clarivate Sells Life Sciences And Healthcare Biz For $600M - Law360
Clarivate PLC Update Call Transcript - GuruFocus
Clarivate to Sell Life Sciences & Healthcare Segment to Altaris for $600 Million - Moomoo
Clarivate (NYSE: CLVT) to divest Life Sciences & Healthcare arm for $600M - Stock Titan
CLVTClarivate Plc Dividends - Finviz
Clarivate (CLVT) M&A announcement Summary - Quartr
Altaris, LLC entered into a definitive agreement to acquire Life Sciences & Healthcare Business from Clarivate Plc (NYSE : CLVT) for $600 million. - marketscreener.com
Clarivate Plc (CLVT) Clarivate PlcM&A CallSlideshow (NYSE:CLVT) 2026-07-06 - Seeking Alpha
Clarivate to sell life sciences unit for $600 million By Investing.com - Investing.com South Africa
Clarivate sells Life Sciences unit for $600M - grafa.com
Clarivate plc Reaffirms Earnings Guidance for the Full Year Ending December 31, 2026 - marketscreener.com
What's Going on With Clarivate Stock Monday?Clarivate (NYSE:CLVT) - Benzinga
Clarivate Plc (CLVT) Shares Surge After $600M Divestiture Agreem - GuruFocus
Clarivate to sell life sciences unit for $600 million - Investing.com
Clarivate Sees FY Loss $461M-Loss $371M >CLVT - Moomoo
Clarivate to sell Life Sciences & Healthcare for $600M, to use proceeds to reduce debt - TradingView
(CLVT) Clarivate Plc Expects FY Adjusted EPS Range $0.70$0.80 - marketscreener.com
(CLVT) Clarivate Plc Expects FY Revenue Range $2.30B$2.42B - marketscreener.com
Clarivate (NYSE: CLVT) divests LS&H unit for $600M to cut debt and lift margins - Stock Titan
Clarivate Reaffirms Full-Year 2026 Fincl Outlook >CLVT - Moomoo
Clarivate Sees FY Adj EPS 70c-Adj EPS 80c >CLVT - Moomoo
Clarivate Announces Sale of Life Sciences & Healthcare Segment f - GuruFocus
Clarivate (CLVT) Launches IPOne AI-Powered Intelligence Platform for IP Workflows - Yahoo Finance
Clarivate to Present at the Barclays Global Technology, Media an - GuruFocus
Clarivate (CLVT) director takes $28,750 retainer in shares, withholds stock for taxes - Stock Titan
13,310-share award for Clarivate (CLVT) director, 2,662 withheld for tax - Stock Titan
Clarivate (CLVT) director Snyder takes share retainer and reports tax withholding - Stock Titan
Clarivate PLC (CLVT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Saluting the team behind BioWorld's haul of seven APEX Awards - Clarivate
Clarivate (CLVT) Index Shift Sparks Questions About Its Evolving Investor Base And Valuation Story - simplywall.st
Introducing EndNote Fusion: Advancing the next generation of reference management - Clarivate
UPC opt-out and opt-in strategy: what the data shows - Clarivate
Clarivate Plc(NYSE: CLVT) added to Russell 2000 Index - marketscreener.com
Clarivate Plc(NYSE: CLVT) dropped from Russell Midcap Value Benchmark - marketscreener.com
Clarivate Plc(NYSE: CLVT) added to Russell 2000 Value Benchmark - marketscreener.com
Clarivate Plc(NYSE: CLVT) dropped from Russell 1000 Value Benchmark - marketscreener.com
Price to book forward of Clarivate Plc – NYSE:CLVT - TradingView
Clarivate Plc(NYSE: CLVT) added to Russell 2000 Dynamic Index - marketscreener.com
Finanzdaten der Clarivate Plc-Aktie (CLVT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.25%
1.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):